North America Cellulite Treatment Market 2023-2030

North America Cellulite Treatment Market 2023-2030

Market Outlook

Triton Market Research’s report reckons that the cellulite treatment market in North America is set to advance with a compound annual growth rate of 9.58% over the forecasting years 2023-2030. Canada and the United States are gauged in the region.

The high prevalence of obesity is expected to drive the market’s growth in Canada. As per estimates, the number of people diagnosed with obesity is expected to rise owing to unhealthy lifestyle choices. This will further elevate the demand for cosmetic procedures to enhance appearance. Moreover, the increase in the geriatric population has also surged the demand for aesthetic treatments like cellulite reduction. In this regard, non-invasive and minimally invasive treatments have significantly backed the expansion of the cellulite treatment market.

Likewise, the high obesity rates have compelled people to opt for various treatments in the US. The availability of minimally invasive procedures has significantly increased the number of patients opting for cellulite treatments. Hence, the growing beauty consciousness and advanced treatments widen the overall scope and growth of the cellulite treatment market across the United States.

Competitive Outlook

The established companies in the cellulite treatment market consist of AbbVie Inc, Bausch Health Companies Inc, Johnson & Johnson, Galderma SA, and Endo International Plc.